Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.
about
A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein AntigensConserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage.Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.Current status and perspectives on protein-based pneumococcal vaccines.Pneumonia and Streptococcus pneumoniae vaccine.Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection.Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice.Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.Determination of avidity of IgG against protein antigens from Streptococcus pneumoniae: assay development and preliminary application in clinical settings.Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan.
P2860
Q26753152-FFC4889F-A232-4474-A761-CC41D5C40CA4Q35092077-87497866-ACC3-4EE8-9FDD-6749A762F75DQ36018177-076768C4-B32A-4580-BD10-6D7CCFF54987Q36191618-CD40188F-A357-43BC-BFBB-9EB7F7983B3BQ36826926-661DF61E-125F-4962-B957-AFFC22504A8AQ37981769-5870D152-DACA-4B24-8AA0-FA0D757D2E8FQ38124921-16FEECAF-51DC-4F68-B237-3881B4E93457Q39452604-F6CEAD1A-8DEE-4FCC-AB5C-B3367A0E70C4Q40240545-6FA7F1B0-D246-46E1-BAD0-F06B758EC905Q42272103-B47C56D8-A91D-405C-9231-FDE8910D0FF7Q44398866-2838831A-06D7-44B8-9E12-64FB12E5583FQ47659427-0B0E4946-1E92-417A-B431-4DF1A09F4E92Q52655234-6FC7CD7C-1C00-4856-B823-D3992F43F87C
P2860
Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Novel protein-based pneumococc ...... ccal disease in neonatal mice.
@ast
Novel protein-based pneumococc ...... ccal disease in neonatal mice.
@en
type
label
Novel protein-based pneumococc ...... ccal disease in neonatal mice.
@ast
Novel protein-based pneumococc ...... ccal disease in neonatal mice.
@en
prefLabel
Novel protein-based pneumococc ...... ccal disease in neonatal mice.
@ast
Novel protein-based pneumococc ...... ccal disease in neonatal mice.
@en
P2093
P2860
P356
P1476
Novel protein-based pneumococc ...... ccal disease in neonatal mice.
@en
P2093
Eszter Nagy
Karen Lingnau
Thorunn Asta Olafsdottir
P2860
P304
P356
10.1128/IAI.05801-11
P407
P577
2011-10-24T00:00:00Z